Cargando…
Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) has one of the poorest prognosis among malignancies. Thus, the identification of markers useful in developing innovative diagnostic and therapeutic methods is an imperative need. Folate receptor alpha (FRα) has been associated with prognosis in several cancers...
Autores principales: | Cai, Lei, Michelakos, Theodoros, Ferrone, Cristina R., Zhang, Liyuan, Deshpande, Vikram, Shen, Qi, DeLeo, Albert, Yamada, Teppei, Zhang, Gong, Ferrone, Soldano, Wang, Xinhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514937/ https://www.ncbi.nlm.nih.gov/pubmed/28430580 http://dx.doi.org/10.18632/oncotarget.16841 |
Ejemplares similares
-
A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma
por: Liu, Zhenyang, et al.
Publicado: (2020) -
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
por: Michelakos, Theodoros, et al.
Publicado: (2022) -
Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020) -
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020) -
Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma
por: Wei, Xiaolin, et al.
Publicado: (2023)